Phase III Study of Envafolimab Versus Placebo Plus Chemotherapy in Resectable Stage III NSCLC
Condition(s):Non-small Cell Lung CancerLast Updated:January 31, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Non-small Cell Lung CancerLast Updated:January 31, 2024Recruiting
Condition(s):Non-small Cell Lung CancerLast Updated:March 20, 2024Active, not recruiting
Condition(s):Stage II-III Non-small Cell Lung CancerLast Updated:June 27, 2023Active, not recruiting
Condition(s):Non-small Cell Lung Cancer (NSCLC)Last Updated:July 24, 2023Withdrawn
Condition(s):Non Small Cell Lung CancerLast Updated:January 23, 2024Active, not recruiting
Condition(s):Non-small Cell Lung CancerLast Updated:August 1, 2023Active, not recruiting
Condition(s):Probiotics Plus ChemotherapyLast Updated:February 25, 2019Unknown status
Condition(s):Carcinoma, Non-Small-Cell LungLast Updated:June 12, 2019Not yet recruiting
Condition(s):Recurrent Ovarian CarcinomaLast Updated:January 2, 2024Active, not recruiting
Condition(s):Non Small Cell Lung CancerLast Updated:November 8, 2018Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.